This will be nowhere near 10x after Phase 1. Phase 1 is to see how safe this is in healthy patients. It has nothing to do with how effective this will be in stroke patients. Maybe after Phase 2 it might take off but that's after success, a few years and more dilution. Would like to see more diversification in their pipeline instead of just the one drug.
This will be nowhere near 10x after Phase 1. Phase 1 is to see...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.010(1.50%) |
Mkt cap ! $81.06M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 66.5¢ | 65.0¢ | $16.55K | 25.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56545 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 13500 | 1 |
View Market Depth
| Last trade - 10.57am 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.5¢ |
Change
-0.010 ( 0.76 %) |
||||
| Open | High | Low | Volume | ||
| 65.5¢ | 65.5¢ | 65.5¢ | 8755 | ||
| Last updated 10.57am 14/05/2024 ? | |||||
| AGN (ASX) Chart |